Childhood Obesity: A Potential Key Factor in the Development of Glioblastoma Multiforme

Abstract

Glioblastoma multiforme (GBM) is a malignant primary tumor type of the central nervous system (CNS). This type of brain tumor is rare and is responsible for 12–15% of all brain tumors. The typical survival rate of GBM is only 12 to 14 months. GBM has a poor and unsatisfactory prognosis despite advances in research and therapeutic interventions via neurosurgery, radiation, and chemotherapy. The molecular heterogeneity, aggressive nature, and occurrence of drug-resistant cancer stem cells in GB restricts the therapeutic efficacy. Interestingly, the CNS tumors in children are the second most usual and persistent type of solid tumor. Since numerous research studies has shown the association between obesity and cancer, childhood obesity is one of the potential reasons behind the development of CNS tumors, including GBM. Obesity in children has almost reached epidemic rates in both developed and developing countries, harming children’s physical and mental health. Obese children are more likely to face obesity as adults and develop non-communicable diseases such as diabetes and cardiovascular disease as compared to adults with normal weight. However, the actual origin and cause of obesity are difficult to be pointed out, as it is assumed to be a disorder with numerous causes such as environmental factors, lifestyle, and cultural background. In this narrative review article, we discuss the various molecular and genetic drivers of obesity that can be targeted as potential contributing factors to fight the development of GBM in children.

Plausible Role of Stem Cell Types for Treating and Understanding the Pathophysiology of Depression

“…Growth factors, transmitters, enzymes, tissue hormones, neuromodulators, and antibodies are predicted to be secreted into the local tissue environment by activated cells, eliciting desirable tissue responses. In damaged neuronal and glial networks, the newly empowered cells and their progeny can operate as functional enhancers and scaffold “healing agents.” These properties have led to substantial advancements in the invention of therapies for trauma and perfusion issues such as stroke [ 112 ], ischemia, or neurodegeneration-related conditions [ 112 , 113 , 114 ]. Not unexpectedly, the prospects of NSCs in mental health care are being hotly debated.…”

Ketamine as a therapeutic agent in major depressive disorder and posttraumatic stress disorder: Potential medicinal and deleterious effects

“…Alternative methods for boosting ketamine's antidepressant effects should also be investigated. The effects of ketamine can also be seen to be differentially precipitated due to various health conditions including diabetes, obesity, cardiovascular conditions, cancer, and other 90–93 . Given these proposed mechanisms of action, other drugs that boost prefrontal plasticity are expected to enhance an antidepressant effects 94 .…”

“…The effects of ketamine can also be seen to be differentially precipitated due to various health conditions including diabetes, obesity, cardiovascular conditions, cancer, and other. 90 , 91 , 92 , 93 Given these proposed mechanisms of action, other drugs that boost prefrontal plasticity are expected to enhance an antidepressant effects. 94 FDA clearance of S‐ketamine for treatment‐resistant MDD is a defining moment in the field of psychiatry.…”

Oxidative Stress Linking Obesity and Cancer: Is Obesity a ‘Radical Trigger’ to Cancer?

“…Or how does obesity in some periods of life affects the risk of tumor later in life? For example, childhood obesity can be a risk factor for some tumor types later in life [142][143][144], while premenopausal overweight women have a lower risk of developing breast cancer [145]. Are some tumor types, developed in tissues not directly involved in metabolism regulation, also triggered by obesity-induced adaptations?…”

“…Recently, Sachdeva et al [144] hypothesized how childhood obesity might be connected to glioblastoma, proposing systemic inflammatory cytokines as one of the contributors. Glioblastoma is the leading cause of brain cancer death; it accounts for about half of the malignant primary brain tumors, with the median survival if treated being 14.6 months [146].…”